TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Onkologia AB
Closing information (x1000 EUR)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
122
|
114 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
109
|
104 | |
| EBITDA |
103
|
104 | |
| Total assets |
329
|
299 | |
| Current assets |
126
|
197 | |
| Current liabilities |
14
|
10 | |
| Equity capital |
315
|
289 | |
| - share capital |
4
|
5 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
95.7%
|
96.7% | |
| Turnover per employee |
122
|
114 | |
| Profit as a percentage of turnover |
89.3%
|
91.2% | |
| Return on assets (ROA) |
33.1%
|
34.8% | |
| Current ratio |
900%
|
1970.0% | |
| Return on equity (ROE) |
34.6%
|
36.0% | |
| Change turnover |
19
|
5 | |
| Change turnover % |
2%
|
18%
|
4% |
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.